Contribution of insulin resistance to vascular dysfunction.
Level 5 - mechanism / opinion, no new human data
Narrative review describing biological mechanisms without original clinical data or systematic review methodology
PubMed 19686034 · doi:10.1080/13813450903136791
What was done
This is a narrative review examining the molecular mechanisms through which insulin affects vascular endothelium and vascular smooth muscle cells in physiological and insulin-resistant states. The authors review insulin signaling via phosphatidylinositol-3 kinase (PI3-K) and mitogen-activated protein kinase (MAPK) pathways, nitric oxide (NO) signaling, endothelin-1 secretion, vascular smooth muscle cell proliferation, and the influence of free fatty acids and cytokines.
What was found
The abstract reports no numerical findings or quantitative effect estimates. It qualitatively describes insulin's dual vascular signaling pathways, highlighting that PI3-K mediates vasodilator actions via NO and cyclic GMP/PKG, whereas MAPK mediates vasoconstrictor and proliferative actions such as endothelin-1 synthesis, with dysregulated pathway interactions occurring in insulin resistance.
Why it matters
The paper outlines how metabolic insulin resistance disrupts the balance between vascular protective and pro-atherogenic signaling pathways. This provides a mechanistic framework linking metabolic syndrome and diabetes to macro- and microvascular disease.
Limits
This is a non-systematic narrative review providing theoretical and mechanistic synthesis rather than original human data or quantitative meta-analysis. No inclusion criteria, sample size, or systematic evaluation of bias are reported.
Cited by
- supports Excess circulating insulin activates intracellular pathways leading to vascular smooth muscle proliferation, reduced cellular autophagy, and an increased risk of cancer.